Gambro expands product recall after more patients die following dialysis treatment
This article was originally published in Clinica
Gambro Healthcare has expanded its recall of blood tubing sets outside the US following the deaths of a further two patients after dialysis treatment. This brings the total number of deaths to four. The company organised the US recall of three lots of COBE Centrysystem 3 blood tubing last month after two patients died and around 30 patients became ill after treatment in clinics in Maryland, Nebraska and Massachusetts (see Clinica No 810, p 10).
You may also be interested in...
The Mallorca-based biotech is building a strong data package for SNF472 which the company believes will be an effective treatment for a number of calcification disorders in dialysis patients.
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.